Cell Cycle/Checkpoint


The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-
BA6150 BMS-37Summary: BMS-37 is an immune checkpoint inhibitor. -
BA6151 TagitanlimabSummary: Tagitanlimab has the potential to study recurrent or metastatic nasopharyngeal carcinoma (NPC). -
BA6152 PD-1-IN-24Summary: Inhibitors with oral activity. -
BA6155 ReozalimabSummary: Reozalimab is a targeted bispecific antibody. -
BA6156 NSC622608Summary: NSC622608 is a T cell activation V structural domain Ig inhibitor ligand. -
BA6157 IvonescimabSummary: Ivonescimab (AK112) is a /bispecific antibody. -
BA6158 GilvetmabSummary: Gilvetmab is a potent canine-derived anti-monoclonal antibody. -
BA6160 SocazolimabSummary: Socazolimab (ZKAB001) is a monoclonal antibody. -
BA6162 mPGES1-IN-7Summary: mPGES-1-IN-2 is an inhibitor of benzimidazoles and also inhibits lipofectamine-based PGD synthase (I-PGDS) (5 μM -
BA6391 DHFR-IN-4Summary: DHFR-IN-4 is a potent dihydrofolate reductase inhibitor.

